Alzheimer’s disease (AD), today is the most prevalent form of dementia afflicting more than 50 million people worldwide (Queiroz et al., 2022, Varesi et al., 2022), and with a doubling time of 20 years could easily...read more
Category - Microbiome
Time Is What We Want Most – Why Wasting Any More of It?
As many of us continuously experience, combing through the latest news in any scientific research area or a given commercial sector – whether it is to stay up-to-date in a specific field, view the latest trends in...read more
We Invite you to join enlightenbio’s Subject Matter Expert Network!
enlightenbio is a boutique consultancy providing product strategy and market intelligence to precision medicine industries. Our mission is to help our clients successfully develop, launch, and market exceptional...read more
Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle
Commitment from Cornerstone Investor LifeArc to Advance Genomics Startups in the UK SAN DIEGO–(BUSINESS WIRE)– Feb. 8, 2021 — Illumina, Inc. (NASDAQ: ILMN) has selected nine new genomics companies to...read more
